Why the study?
Evidence regarding the predictive ability of the triglyceride-glucose index for all-cause and cardiac mortality in patients with CHD after PCI remains limited.
Does an elevated triglyceride-glucose (TyG) index predict all-cause and cardiac mortality in patients with coronary heart disease undergoing PCI?
Population
2,533 CHD patients who underwent PCI
Comparison
Higher vs lower TyG levels
Design
Secondary analysis using data from the Dryad database
Key result
An elevated Triglyceride-glucose (TyG) index was independently associated with an increased risk of all-cause mortality (OR 1.7) and cardiac mortality in patients with coronary heart disease undergoing percutaneous coronary intervention.
Authors
Loading...
TyG index may aid post-PCI mortality risk stratification; leaves open need for prospective validation before clinical adoption.
Cohort (n=2,533)
No
Does an elevated triglyceride-glucose (TyG) index predict all-cause and cardiac mortality in patients with coronary heart disease undergoing PCI?
Odds Ratio: 1.7 (95% CI 1.1–2.7)
p-value: p=0.030
An elevated triglyceride-glucose index is independently associated with an increased risk of all-cause and cardiac mortality in patients with coronary heart disease following PCI.
Wan et al. (2026) conducted a cohort in Coronary heart disease (CHD) following percutaneous coronary intervention (PCI) (n=2,533). Elevated Triglyceride-glucose (TyG) index vs. Lower Triglyceride-glucose (TyG) index was evaluated on All-cause death (OR 1.7, 95% CI 1.1-2.7, p=0.030). An elevated Triglyceride-glucose (TyG) index was independently associated with an increased risk of all-cause mortality (OR 1.7) and cardiac mortality in patients with coronary heart disease undergoing percutaneous coronary intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: